eColl™

A variety of high potential collagen tissue engineering products (Xenografts) for multiple clinical applications are being developed. Modern tissue engineering approaches will be used to treat children with structural birth disorders, such as spina bifida, urogenital defects, gastroschisis, diaphragmatic hernia and esophageal atresia.

Recently, a platform is created for the development of collagen tissue engineering scaffolds for bladder augmentation (i.e. bladder cancer), treatment of hypospadia and epispadia, and application as urostomy. Highly-purified type I collagen can be obtained from several sources such as tendon, skin and/or pericardium. From the latter, collagen fleece can be made which is already on the market as Jason^® and applied to minor wounds in implantology, periodontology and oral surgery.

Outstanding product features:

• Natural molecule
• Highly biocompatible
• Resorbable to the body
• Differently shaped and sized for various clinical applications:
  • flat (Vesicoll^®), for bladder augmentation
  • tubular small diameter (Tubecoll^®), for urethra replacement (hypospadia, epispadia)
  • tubular large diameter (Divecoll^®), as urostomy

Products under the eColl™ family include:

• Bovine & porcine dermis
• Bovine & porcine pericard
• Porcine fleece
• Bovine collaged based tubular
• Flat scaffolds

Which are suited for applications that range from periodontology to wound/infection care. From maxillofacial reconstruction to tissue regeneration, from gynecology to urology.

Furthermore, EMCM has developed a method for a cost efficient and reliable technique for the manufacture of Ultra-pure type 2 bovine fibrillar collagen and is working on developing a variant of Atelocollagen, new sources of collagen and much more.

The eColl™ products are in various stages of development and will be classified as a Medical Device (CE)